MHRA Drug & Device Safety Alerts

Safety alerts, recalls, and field safety notices from the Medicines and Healthcare products Regulatory Agency — covering drug safety updates, medical device alerts, and class recalls.

514
Total Alerts
250
Drug Safety Updates
264
Device Alerts

Alerts by Type

Key Insights

514 MHRA alerts tracked. 250 Drug Safety Updates. 264 Medical Device Alerts.

MHRA alerts link to NHS trusts and healthcare bodies — cross-reference with responsible body scorecard pages to surface patterns between safety alert volumes and inquiry recommendation delivery.

Showing 514 alerts

Letters and medicine recalls sent to healthcare professionals in February 2023
letters-and-medicine-recalls-sent-to-healthcare-professionals-in-february-2023 Drug Safety
23 Mar 2023 MHRA
Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure
pholcodine-containing-cough-and-cold-medicines-withdrawal-from-uk-market-as-a-precautionary-measure Drug Safety
23 Mar 2023 MHRA
COVID-19 vaccines and medicines: updates for March 2023
covid-19-vaccines-and-medicines-updates-for-march-2023 Drug Safety
23 Mar 2023 MHRA
Field Safety Notices: 6 to 10 March 2023
field-safety-notices-6-to-10-march-2023 Medical Device Alert
17 Mar 2023 MHRA
COVID-19 vaccines and medicines: updates for February 2023
covid-19-vaccines-and-medicines-updates-for-february-2023 Drug Safety
27 Feb 2023 MHRA
Letters and medicine recalls sent to healthcare professionals in January 2023
letters-and-medicine-recalls-sent-to-healthcare-professionals-in-january-2023 Drug Safety
27 Feb 2023 MHRA
NexGen Knee replacement: affected patients should be offered additional follow up, DSI/2023/003
nexgen-knee-replacement-affected-patients-should-be-offered-additional-follow-up Medical Device Alert
15 Feb 2023 MHRA
Field Safety Notices: 6 to 10 February 2023
field-safety-notices-6-to-10-february-2023 Medical Device Alert
13 Feb 2023 MHRA
Field Safety Notices: 30 January to 3 February 2023
field-safety-notices-30-january-to-3-february-2023 Medical Device Alert
06 Feb 2023 MHRA
Topical testosterone (Testogel): risk of harm to children following accidental exposure
topical-testosterone-testogel-risk-of-harm-to-children-following-accidental-exposure Drug Safety
25 Jan 2023 MHRA
Electronic Prescribing and Medicines Administration Systems: report adverse incidents on a Yellow Card
electronic-prescribing-and-medicines-administration-systems-report-adverse-incidents-on-a-yellow-car Drug Safety
25 Jan 2023 MHRA
Letters and medicine recalls sent to healthcare professionals in December 2022
letters-and-medicine-recalls-sent-to-healthcare-professionals-in-december-2022 Drug Safety
25 Jan 2023 MHRA
COVID-19 vaccines and medicines: updates for January 2023
covid-19-vaccines-and-medicines-updates-for-january-2023 Drug Safety
25 Jan 2023 MHRA
Xaqua (metolazone) 5mg tablets: exercise caution when switching patients between metolazone preparations
xaqua-metolazone-5mg-tablets-exercise-caution-when-switching-patients-between-metolazone-preparation Drug Safety
25 Jan 2023 MHRA
Field Safety Notices: 9 to 13 January 2023
field-safety-notices-9-to-13-january-2023 Medical Device Alert
16 Jan 2023 MHRA
Letters and medicine recalls sent to healthcare professionals in November 2022
letters-and-medicine-recalls-sent-to-healthcare-professionals-in-november-2022 Drug Safety
12 Dec 2022 MHRA
Valproate: reminder of current Pregnancy Prevention Programme requirements; information on new safety measures to be in…
valproate-reminder-of-current-pregnancy-prevention-programme-requirements-information-on-new-safety- Drug Safety
12 Dec 2022 MHRA
COVID-19 vaccines and medicines: updates for December 2022
covid-19-vaccines-and-medicines-updates-for-december-2022 Drug Safety
12 Dec 2022 MHRA
COVID-19 vaccines and medicines: updates for November 2022
covid-19-vaccines-and-medicines-updates-for-november-2022 Drug Safety
29 Nov 2022 MHRA
Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management
dupilumab-dupixentv-risk-of-ocular-adverse-reactions-and-need-for-prompt-management Drug Safety
29 Nov 2022 MHRA
Letters and medicine recalls sent to healthcare professionals in October 2022
letters-and-medicine-recalls-sent-to-healthcare-professionals-in-october-2022 Drug Safety
29 Nov 2022 MHRA
Consultation with healthcare professionals: please complete our consultation to help influence how we communicate with …
consultation-with-healthcare-professionals-please-complete-our-consultation-to-help-influence-how-we Drug Safety
29 Nov 2022 MHRA
Field Safety Notices: 21 to 25 November 2022
field-safety-notices-21-to-25-november-2022 Medical Device Alert
28 Nov 2022 MHRA
Letters and medicine recalls sent to healthcare professionals in September 2022
letters-and-medicine-recalls-sent-to-healthcare-professionals-in-september-2022 Drug Safety
25 Oct 2022 MHRA
COVID-19 vaccines and medicines: updates for October 2022
covid-19-vaccines-and-medicines-updates-for-october-2022 Drug Safety
25 Oct 2022 MHRA
MedSafetyWeek November 2022: Every Yellow Card report helps to improve patient safety
medsafetyweek-november-2022-every-yellow-card-report-helps-to-improve-patient-safety Drug Safety
25 Oct 2022 MHRA
Field Safety Notices: 10 to 14 October 2022
field-safety-notices-10-to-14-october-2022 Medical Device Alert
17 Oct 2022 MHRA
Field Safety Notices: 04 to 08 October 2021
field-safety-notices-04-to-08-october-2021 Medical Device Alert
11 Oct 2022 MHRA
Field safety notice (FSN) 03 to 07 October
field-safety-notice-fsn-03-to-07-october Medical Device Alert
10 Oct 2022 MHRA
Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences i…
methylphenidate-long-acting-modified-release-preparations-caution-if-switching-between-products-due- Drug Safety
26 Sep 2022 MHRA
Letters and medicine recalls sent to healthcare professionals in August 2022
letters-and-medicine-recalls-sent-to-healthcare-professionals-in-august-2022 Drug Safety
26 Sep 2022 MHRA
Rucaparib (Rubraca▼): withdrawal of third-line treatment indication
rucaparib-rubracav-withdrawal-of-third-line-treatment-indication Drug Safety
26 Sep 2022 MHRA
COVID-19 vaccines and medicines: updates for September 2022
covid-19-vaccines-and-medicines-updates-for-september-2022 Drug Safety
26 Sep 2022 MHRA
Field Safety Notices: 29 August to 2 September 2022
field-safety-notices-29-august-to-2-september-2022 Medical Device Alert
05 Sep 2022 MHRA
Letters and medicine recalls sent to healthcare professionals in July 2022
letters-and-medicine-recalls-sent-to-healthcare-professionals-in-july-2022 Drug Safety
23 Aug 2022 MHRA
COVID-19 vaccines and medicines: updates for August 2022
covid-19-vaccines-and-medicines-updates-for-august-2022 Drug Safety
23 Aug 2022 MHRA
Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and manage…
nebulised-asthma-rescue-therapy-in-children-home-use-of-nebulisers-in-paediatric-asthma-should-be-in Drug Safety
23 Aug 2022 MHRA
Field Safety Notices: 11 to 15 July 2022
field-safety-notices-11-to-15-july-2022 Medical Device Alert
08 Aug 2022 MHRA
Field Safety Notices: 18 to 22 July 2022
field-safety-notices-18-to-22-july-2022 Medical Device Alert
25 Jul 2022 MHRA
COVID-19 vaccines and medicines: updates for July 2022
covid-19-vaccines-and-medicines-updates-for-july-2022 Drug Safety
21 Jul 2022 MHRA
Letters and medicine recalls sent to healthcare professionals in June 2022
letters-and-medicine-recalls-sent-to-healthcare-professionals-in-june-2022 Drug Safety
21 Jul 2022 MHRA
Topiramate (Topamax): start of safety review triggered by a study reporting an increased risk of neurodevelopmental dis…
topiramate-topamax-start-of-safety-review-triggered-by-a-study-reporting-an-increased-risk-of-neurod Drug Safety
21 Jul 2022 MHRA
Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk
metformin-and-reduced-vitamin-b12-levels-new-advice-for-monitoring-patients-at-risk Drug Safety
20 Jun 2022 MHRA
Roche Accu-Chek Insight insulin pump with NovoRapid PumpCart insulin cartridges: alert following cases of insulin leaka…
roche-accu-chek-insight-insulin-pump-with-novorapid-pumpcart-insulin-cartridges-alert-following-case Drug Safety
20 Jun 2022 MHRA
COVID-19 vaccines and medicines: updates for June 2022
covid-19-vaccines-and-medicines-updates-for-june-2022 Drug Safety
20 Jun 2022 MHRA
Letters and medicine recalls sent to healthcare professionals in May 2022
letters-and-medicine-recalls-sent-to-healthcare-professionals-in-may-2022 Drug Safety
20 Jun 2022 MHRA
Field Safety Notices: 23 to 27 May 2022
field-safety-notices-23-to-27-may-2022 Medical Device Alert
30 May 2022 MHRA
Field Safety Notices: 16 to 20 May 2022
field-safety-notices-16-to-20-may-2022 Medical Device Alert
24 May 2022 MHRA
COVID-19 vaccines and medicines: updates for May 2022
covid-19-vaccines-and-medicines-updates-for-may-2022 Drug Safety
17 May 2022 MHRA
Denosumab 60mg (Prolia): should not be used in patients under 18 years due to the risk of serious hypercalcaemia
denosumab-60mg-prolia-should-not-be-used-in-patients-under-18-years-due-to-the-risk-of-serious-hyper Drug Safety
17 May 2022 MHRA